Gastrobody Therapeutics is a biopharmaceutical company creating ultrastable, orally-administered protein therapeutics to treat conditions of the gastrointestinal (GI) tract.

Gastrobodies have the potential to be transformative against GI tract diseases by leveraging their specificity to the target and their unique ability to survive the harsh conditions within the GI tract.